The immune dysfunction and cell destruction that occur in the human immunod
eficiency virus (HIV)-infected host appear to result from the direct cytopa
thic effects of viral infection and the effects of viral proteins on uninfe
cted bystander cells, Recently, the alpha-chemokine receptor CXCR4 has been
reported to mediate apoptosis in neuronal cells and in CD4(+) and CD8(+) T
cells after its binding to HIV-1 envelope proteins. In the current study,
it was observed that human umbilical vein endothelial cells (HUVEC) undergo
apoptosis after their treatment with the HIV-1 envelope proteins gp120/160
. Anti-CXCR4 monoclonal antibody decreased HIV-1 gp120/160-induced apoptosi
s, suggesting that the CXCR4 chemokine receptor mediates the apoptotic effe
cts of these HIV envelope glycoproteins, Further studies revealed that casp
ases play an important role in this process because the pretreatment of cel
ls with a general caspase enzyme inhibitor decreased the extent of HUVEC ap
optosis induced by gp120/160, In addition, it was found that caspase-3 was
activated on HIV-1 gp120/160 treatment of these cells. It was also observed
that gp120/160 treatment slightly increased the expression of the pro apop
totic molecule Bar. These results suggest that HIV-1 envelope glycoproteins
can disrupt endothelial integrity through the interaction with CXCR4, ther
eby facilitating virus transit out of the bloodstream and contributing to t
he vascular injury syndromes seen in acquired immunodeficiency syndrome. (B
lood. 2000;96:1438-1442) (C) 2000 by The American Society of Hematology.